Blood loss and transfusion needs reduced with TXA in major orthopaedic surgery
The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysisJ Surg Res. 2014 Jan;186(1):318-27. doi: 10.1016/j.jss.2013.08.020. Epub 2013 Sep 13
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
46 randomized controlled trials were included in this meta-analysis to investigate the use of tranexamic acid (TXA) in major orthopaedic surgery. The purpose of this analysis was to determine if blood loss and transfusion requirements were reduced with the application of TXA. Results revealed that intraoperative, postoperative and total blood loss were significantly reduced with tranexamic acid. T...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE